Derivative (7)t(7;8)(q34;q21): A new additional cytogenetic abnormality in acute promyelocytic leukemia

Cancer Genetics and Cytogenetics

Volumn 140, Issue 1, 2003, Pages 78-81

  Vial, Jean Philippe ^a   Mahon, François Xavier ^a   Pigneux, Arnaud ^b   Notz, Anne ^c   Lacombe, Francis ^a   Reiffers, Josy ^b   Bilhou Nabera, Chrystèle ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b Service des Maladies du Sang   (France)

^c HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; ASPARAGINASE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; RETINOIC ACID;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CHROMOSOME TRANSLOCATION 7; CHROMOSOME TRANSLOCATION 8; CLINICAL FEATURE; FEMALE; GENE LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY TEST; LEUKOPENIA; LONG TERM CARE; PRIORITY JOURNAL; PROGNOSIS; PROMYELOCYTIC LEUKEMIA; SCHOOL CHILD; TRISOMY 8;

AGED; BREAST NEOPLASMS; CHILD; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, PROMYELOCYTIC, ACUTE; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; TRANSLOCATION, GENETIC; TRISOMY;

EID: 0037238252     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00634-9     Document Type: Article

References (17)

1. Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C., Harrison G., Rees J., Hann I., Stevens R., Burnett A., Goldstone A. The importance of diagnostic cytogenetics on outcome in AML. analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties Blood. 92:1998;2322-2333.
2. Pantic M., Novak A., Marisavljevic D., Djordjevic V., Elezovic I., Vidovic A., Colovic M. Additional chromosome aberrations in acute promyelocytic leukemia. characteristics and prognostic influence Med Oncol. 17:2000;307-313.
3. De Botton S., Chevret S., Sanz M., Dombret H., Thomas X., Guerci A., Fey M., Rayon C., Huguet F., Sotto J.J., Gardin C., Cony Makhoul P., Travade P., Solary E., Fegueux N., Bordessoule D., San Miguel J., Link H., Desablens B., Stamatoullas A., Deconinck E., Geiser K., Hess U., Maloisel F., Castaigne S., Preudhomme C., Chomienne C., Degos L., Fenaux P. Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis. results of APL 93 trial Br J Haematol. 111:2000;801-806.
4. Hernandez J.M., Martin G., Gutierrez N.C., Cervera J., Ferro M.T., Calasanz M.J., Martinez-Climent J.A., Luno E., Tormo M., Rayon C., Diaz-Mediavilla J., Gonzalez M., Gonzalez-San Miguel J.D., Perez-Equiza K., Rivas C., Esteve J., Alvarez Mdel C., Odriozola J., Ribera J.M., Sanz M.A. Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA. Haematologica. 86:2001;807-813.
5. Batanian J.R., Ma E., Huang Y., Gadre B. Co-existence of alternative forms of 8q gain in cytogenetic clones of three patients with acute myeloid leukemia, pointing to 8q22 approximately 8qter as a region of biologic significance. Cancer Genet Cytogenet. 126:2001;20-25.
6. Michel G., Leverger G., Leblanc T., Nelken B., Baruchel A., Landman-Parker J., Thuret I., Bergeron C., Bordigoni P., Esperou-Bourdeau H., Perel Y., Vannier J.P., Schaison G. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP). Bone Marrow Transplant. 17:1996;191-196.
7. Vial J.P., Lacombe F. Immunophenotyping of acute leukemia. utility of CD45 for blast cell identification Methods Cell Biol. 64:2001;343-358.
8. ISCN. An international system for human cytogenetic nomenclature. Mitelman F, editor. Basel: S. Karger, 1995.
9. van Dongen J.J., Macintyre E.A., Gabert J.A., Delabesse E., Rossi V., Saglio G., Gottardi E., Rambaldi A., Dotti G., Griesinger F., Parreira A., Gameiro P., Diaz M.G., Malec M., Langerak A.W., San Miguel J.F., Biondi A. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action. investigation of minimal residual disease in acute leukemia Leukemia. 13:1999;1901-1928.
10. Lacombe F., Durrieu F., Briais A., Dumain P., Belloc F., Bascans E., Reiffers J., Boisseau M.R., Bernard P. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia. 11:1997;1878-1886.
11. Schoch C., Haase D., Fonatsch C., Haferlach T., Loffler H., Schlegelberger B., Hossfeld D.K., Becher R., Sauerland M.C., Heinecke A., Wormann B., Buchner T., Hiddemann W. The significance of trisomy 8 in de novo acute myeloid leukaemia. the accompanying chromosome aberrations determine the prognosis German AML Cooperative Study Group. Br J Haematol. 99:1997;605-611.
12. Hiorns L.R., Min T., Swansbury G.J., Zelent A., Dyer M.J., Catovsky D. Interstitial insertion of retinoic acid receptor-alpha gene in acute promyelocytic leukemia with normal chromosomes 15 and 17. Blood. 83:1994;2946-2951.
13. Qumsiyeh M.B., Cheng C., Eyre J., Mann K.P., Zhang X.X. Tetrasomy 8 evolving into a segmental triplication 8q in a case of acute monocytic leukemia. Cancer Genet Cytogenet. 116:2000;74-76.
14. Misawa S., Staal S.P., Testa J.R. Amplification of the c-myc oncogene is associated with an abnormally banded region on chromosome 8 or double minute chromosomes in two HL-60 human leukemia sublines. Cancer Genet Cytogenet. 28:1987;127-135.
15. Michalova K., Cermak J., Brezinova J., Zemanova Z. Double minute chromosomes in a patient with myelodysplastic syndrome transforming into acute myeloid leukemia. Cancer Genet Cytogenet. 109:1999;76-78.
16. Bruckert P., Kappler R., Scherthan H., Link H., Hagmann F., Zankl H. Double minutes and c-MYC amplification in acute myelogenous leukemia. Are they prognostic factors? Cancer Genet Cytogenet. 120:2000;73-79.
17. Johnson E., Cotter F.E. Monosomy 7 and 7q- associated with myeloid malignancy. Blood Rev. 11:1997;46-55.